AUR-101 by Aurigene Oncology for Psoriatic Arthritis: Likelihood of Approval

AUR-101 is under clinical development by Aurigene Oncology and currently in Phase II for Psoriatic Arthritis.

Pharmalittle: We’re reading about Roche plans for Flatiron, underwhelming Novo Nordisk earnings, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

August 7, 2024

Study aims to explore the underlying causes of excessive alcohol production in overweight people

The microorganisms in the intestines of many overweight people produce alcohol to an increased extent, as Max Nieuwdorp, professor of Internal Medicine at Amsterdam UMC

April 13, 2024

Why AI Can Potentially Revolutionize Breast Cancer Detection

Teri Thomas, CEO and Managing Director at Volpara Health Breast cancer awareness is essential for early detection, which is critical for improving survival rates and

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.